CytoMed Therapeutics Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CytoMed Therapeutics Limited generated cash of -$2,601,298, which is less than the previous year. Cash used in financing activities reached the amount of $8,274,771 last year. Net change in cash is therefore $3,507,496.
Cash Flow
| 2019 | -347.54K | -642.99K | 653.50K |
|---|---|---|---|
| 2020 | -849.44K | -513.05K | 1.88M |
| 2021 | -1.71M | -823.66K | 4.17M |
| 2022 | -1.03M | -351.59K | 719.61K |
| 2023 | -2.60M | -2.13M | 8.27M |
GDTC Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 1.17M | 1.86M | 885.27K | 370.94K | 726.85K |
Operating activities | |||||
Net income | -3.13M | -2.32M | -2.05M | -1.93M | -465.95K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 287.84K | 291.84K | 329.87K | 292.53K | 97.22K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -3.97K | -107.84K | -433.11K | -162.05K | 5.24K |
Inventories | 0 | 0 | 0 | 0 | -26.10K |
Accounts payable | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -2.60M | -1.03M | -1.71M | -849.44K | -347.54K |
Investing activities | |||||
Purchases Of Investments | -2.09M | 0 | 0 | -247.89K | 0 |
Investments In Property Plant And Equipment | -44.17K | -351.96K | -582.35K | -265.15K | -642.99K |
Acquisitions Net | 0 | 0 | -241.31K | 0 | 0 |
Cash generated by investing activities | -2.13M | -351.59K | -823.66K | -513.05K | -642.99K |
Financing activities | |||||
Common Stock Issued | 11.30M | 908.25K | 2M | 500K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -340.42K | -128.75K | -58.90K | -10.95K | 0 |
Cash used in financing activities | 8.27M | 719.61K | 4.17M | 1.88M | 653.50K |
Net Change In Cash | 3.50M | -693.12K | 1.62M | 514.33K | -523.69K |
Cash at end of period | 4.70M | 1.17M | 2.51M | 885.27K | 203.16K |
| Data source | Data source |